EUIPO sides with Takeda in trademark appeal
28-11-2018
Japanese Takeda to acquire Shire for $62bn
08-05-2018
Takeda makes fourth offer to buy Shire
23-04-2018
william_potter / iStockphoto.com
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Takeda Pharmaceuticals, Shire, acquisition, European Commission, regulatory approval, debt, over-the-counter, Federal Trade Commission
